BioSpace News Archive

BioMed X announced the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs.

INOVIO today announced that an abstract has been accepted for oral presentation on INO-3107 for the treatment of Recurrent Respiratory Papillomatosis (RRP) at this year’s American Broncho-Esophagological Association (ABEA) program at the Combined Otolaryngology Spring Meetings (COSM) in Boston, Massachusetts.

The Rare Medical Network (RMN) announced the results of a study designed to measure the educational value of the RMN specialty-specific websites to healthcare professionals.

Pattern Bioscience, Inc. today announced the completion of a $28.7 million Series C financing.

Endologix LLC has announced the online publication of the final five-year results of the LEOPARD Trial in the Journal of Vascular Surgery.

MiNK Therapeutics, Inc. today announced that the Company will release its first quarter 2023 financial results before the market opens on Thursday, May 11, 2023.

Avenue Therapeutics, Inc. today announced that Alexandra MacLean, M.D., Chief Executive Officer, will present a corporate update at the Aegis Capital Virtual Conference taking place on Thursday, May 4, 2023, at 4:00 p.m. EDT.

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 first quarter financial results before the market opens on Thursday, May 4th.

Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind” or “the company”) today announced it has formed a Data and Safety Monitoring Board (DSMB) to oversee the company’s first in human clinical trial, for Alcohol Use Disorder (“AUD”) treatment.

Cryoport, Inc. today announced that the Company will report financial results for the first quarter ended March 31, 2023.